Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01061528 · ClinicalTrials.gov registry record · NA

Coping Skills Treatment for Smoking Cessation

A NA study, sponsored by Butler Hospital.

Completed
Registry status
NA
Development phase
116
Enrollment target

NCT01061528 is a NA study that has completed, run by Butler Hospital. The registered enrollment target is 116 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01061528, a NA study, has completed, sponsored by Butler Hospital.

COMPLETED
Registry status
NA
Development phase
116 participants
Enrollment target

Study Summary

The primary purpose of this study is to evaluate the efficacy of a new type of exposure- and acceptance-based smoking cessation treatment vs. standard behavioral smoking cessation treatment, in conjunction with the use of the transdermal nicotine patch. In both treatments, participants will receive one 60-minute individual session, seven 2-hour group sessions and two individual brief telephone contacts over an eight-week period. Both treatments include 8 weeks of transdermal nicotine patch, which will begin at the time of quitting smoking and will continue after the treatment sessions have ended. Participants will provide follow-up data with regard to their smoking status through a one-year follow-up period.

Interventions

  • DRUG Transdermal Nicotine

Trial Details

FieldValue
Enrollment Target 116 participants
Start Date 2009-09
Est. Completion 2013-10
Phase NA

Sponsor

Butler Hospital

103 total trials

What the Registry Record Tells You About NCT01061528

The ClinicalTrials.gov registry entry for NCT01061528 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Butler Hospital, which has 103 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Transdermal Nicotine is the first listed.

NCT01061528 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01061528 about?

NCT01061528 is a clinical study titled "Coping Skills Treatment for Smoking Cessation". The primary purpose of this study is to evaluate the efficacy of a new type of exposure- and acceptance-based smoking cessation treatment vs. standard behavioral smoking cessation treatment, in conjunction with the use of the transdermal nicotine patch. In both treatments, participants will receive ...

What is the current status of trial NCT01061528?

This trial is currently completed. It is a NA study. The enrollment target is 116 participants. The study started on 2009-09. Estimated completion is 2013-10.

What interventions are being tested in trial NCT01061528?

The interventions under investigation include: Transdermal Nicotine (DRUG).

Who is sponsoring clinical trial NCT01061528?

This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.